Neovasc (NVCN) Stock Analysis

What Neovasc does

Neovasc Inc. is a specialized medical technology enterprise focused on the development, production, and worldwide distribution of products for the cardiac health sector, with a significant presence across Europe and other international markets. The company's key innovations feature the Tiara system, an advanced transcatheter technology for managing mitral valve disease, and the Neovasc Reducer, which offers a therapeutic option for patients suffering from refractory angina. Founded in 2000, the organization initially operated as Medical Ventures Corp. before adopting the name Neovasc Inc. in July 2008. Its corporate headquarters are situated in Richmond, Canada.

Key metrics

ETFs linked to NVCN

Broad-market and Healthcare sector ETFs an investor holding Neovasc is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NVCN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Neovasc?

Neovasc trades under the ticker NVCN on NASDAQ.

Which exchange is NVCN listed on?

NVCN is listed on NASDAQ.

What sector does Neovasc operate in?

Neovasc is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze NVCN in a portfolio?

PortView shows NVCN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.